Go to the "Data" Tab: Click on the "Data" tab in the Excel ribbon. Select "From Text/CSV": In the "Get & Transform Data" ...
WATERTOWN, Mass. - Acrivon Therapeutics, Inc. (NASDAQ:ACRV), a clinical-stage biotech company with a market capitalization of $64.17 million and strong cash reserves exceeding its debt obligations, ...
BRISBANE, Calif. - Pacira BioSciences, Inc. (NASDAQ:PCRX), a $1.04 billion biopharmaceutical company currently trading below its InvestingPro Fair Value, will present new data from its Phase 1 ...
BAAR, Switzerland - Novocure (NASDAQ:NVCR), a $1.47 billion medical technology company whose shares have declined over 55% year-to-date, will present research data on its Tumor Treating Fields ...
TOKYO, Oct. 14, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that VEOZAH™ (fezolinetant), its first-in-class, targeted, ...
Hosted on MSN
CBSE reminds schools to submit registration data for class 9 and 11 students by October 16: Check details here
The Central Board of Secondary Education (CBSE) has issued a fourth reminder to all affiliated schools regarding the submission of registration data for Class IX and Class XI for the academic year ...
Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral ...
PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #ESMO--Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology portfolio and pipeline at ...
I don’t use Microsoft Excel all that often, so it remains a bit of a mystery to me. I can enter text and create graphs and that’s basically it. That’s why I’ve set myself a goal to learn one new Excel ...
Connecting the dots: US economic growth in 2025 is being driven by an unprecedented surge in AI-related infrastructure spending – an inversion of the forces that have long powered expansion. The boom ...
Sarepta Therapeutics Inc. (NASDAQ:SRPT) stock is trading higher on Wednesday, with apparently no news to justify the movement. This week, Sarepta will present data from its gene therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback